David Andreu (PhD, University of Barcelona, 1981) trained as a peptide chemist with Nobel laureate Bruce Merrifield at Rockefeller University (1982-85), served as associate professor at the University of Barcelona (1986-2001) and in 2002 was appointed professor of Chemistry at Pompeu Fabra University, Barcelona, where he leads the protein chemistry and proteomics group, with focus on peptide-based vaccines and pharmaceuticals. He is the current president of the European Peptide Society and the editor-in-chief of Drugs of the Future, and has served on the board of the Spanish Proteomics Society and the Spanish Society of Medicinal Chemistry. David’s main role as facility head is to discuss synthesis jobs and offer post-service advice & followup to users.